Curcumin nanoparticles: physico-chemical fabrication and its in vitro efficacy against human pathogens by unknown
ORIGINAL ARTICLE
Curcumin nanoparticles: physico-chemical fabrication and its
in vitro efficacy against human pathogens
Raksha S. Pandit1 • Swapnil C. Gaikwad1 • Gauravi A. Agarkar1 •
Aniket K. Gade1 • Mahendra Rai1
Received: 10 January 2015 / Accepted: 15 April 2015 / Published online: 7 May 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Curcumin is one of the polyphenols, which has
been known for its medicinal use since long time. Cur-
cumin shows poor solubility and low absorption, and
therefore, its use as nanoparticles is beneficial due to their
greater solubility and absorption. The main aim of the
present study was the formation of curcumin nanoparticles
(Nano curcu), evaluation of their antibacterial activity
against human pathogenic bacteria and formulation of
Nano curcu-based cream. We synthesized Nano curcu by
sonication method. The synthesis of Nano curcu was
assessed for their solubility in water and by UV–visible
spectrophotometry. Further, the nanoparticles were char-
acterized by Fourier transform infrared spectroscopy,
transmission electron microscopy, nanoparticle tracking
and analysis, and zeta potential analysis. In vitro antibac-
terial activity of Nano curcu was evaluated against
Escherichia coli, Staphylococcus aureus, and Pseu-
domonas aeruginosa. The cream containing Nano curcu
was found to be effective against human bacterial patho-
gens and hence can be used for treatment of bacterial
diseases.
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Introduction
Curcuma longa L. is a perennial herb, which belongs to
family Zingiberaceae, and commonly known as turmeric.
It occurs in tropical and sub-tropical regions throughout
the world. It is commonly cultivated in Asian countries,
mostly in India and China and is extensively used in
ayurveda, unani, and siddha systems of medicine as one of
the household therapies to alleviate different diseases
(Araujo and Leon 2000; Chattopadhyay et al. 2004;
Nawaz et al. 2011). Curcumin suppresses the activity of
many bacteria such as Staphylococcus aureus, Salmonella
paratyphi (Chaudhary and Sekhhon 2012) and Bacillus
subtilis, B. macerans, B. licheniformis, and Azotobacter
(Naz et al. 2010). Curcumin is also found to be effective
against 20 types of Candida species (Martins et al. 2009).
It has been observed by trials on human and mouse that
oral consumption of curcumin shows less bioavailability
and it undergoes intestinal metabolism (Sharma et al.
2005; Anand et al. 2007). These obstacles of curcumin
can be eliminated by synthesis of curcumin nanoparti-
cles (Nano curcu), liposomes, micelles, and phospholipid
complexes which can be used for the purpose of longer
circulation, permeability and increased resistance to
metabolic processes (Aggarwal et al. 2006; Nawaz et al.
2011; Ravichandran 2013). Curcumin loaded in poly
(lactic-coglycolic acid) (PLGA) nanospheres was syn-
thesized by using solid/oil/water emulsion solvent
evaporation technique (Mukerjee and Vishwantha 2009).
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which can be used in the cancer therapy (Mukerjee and
Vishwantha 2009). Curcumin-loaded hydrogel nanopar-
ticles can act as an adjuvant in malarial treatment which
reduces the use of antimalarial drugs (Dandekar et al.
2010).
Polymeric synthesis of curcumin-loaded nanoparticles
was found effective against malignant brain tumors by
inhibiting the growth of brain tumor cells (Lim et al.
2011). In vitro study of synthesized nanoparticles by fatty
acid coacervation technique revealed that they are effec-
tive in the treatment of cancer (Chirio et al. 2011). Also,
curcumin-loaded PLGA nanoparticles were found to be
novel candidates in the treatment of ovarian cancer
(Yallapu et al. 2010). It was demonstrated from the study
tha Nano curcu can stop the primary stage of metastasis,
and therefore, it can be used as one of the novel treat-
ments in cancer (Bisht et al. 2007). It was reported that
the synthesis of solid lipid Nano curcu was useful to
enhance the oral bioavailability of curcumin (Bansal and
Munjal 2011). Antibacterial activity of Nano curcu was
tested against different types of Gram-positive and Gram-
negative bacteria (Bhavana et al. 2011). Silver
nanocomposite film of curcumin was very effective ma-
terial for antibacterial application (Varaprasad et al.
2011). The researchers have also prepared sodium car-
boxylmethyl cellulose (SCMC) silver nanocomposite films
(Varaprasad et al. 2011). Curcumin chitosan-poly (vinyl
alcohol)-silver nanocomposite film was prepared by Vimla
et al. (2011) in order to increase applications as antibac-
terial packaging, wound dressing, and antibacterial mate-
rials. Different nanoparticles like curcumin, silver, and
chitosan nanoparticles were synthesized and it was found
that Nano curcu along with silver and chitosan nanopar-
ticles showed anti-parasitic activity against Giardia lam-
blia (Said et al. 2012). Curcumin albumin nanoparticles
were formulated by using desolvation method which is
one of the novel methods of nanoparticles synthesis and
albumin nanoparticles are one of the promising tools for
increasing the action of curcumin as a drug (Jithan et al.
2011).
In the present study, we report physico-chemical syn-
thesis of Nano curcu, their formulation and activity against
Escherichia coli, Staphylococcus aureus, and Pseu-
domonas aeruginosa. The formulated cream is a new




tadiene-3,5-dione] powder was procured from Hi-Media
Laboratories Ltd., Mumbai.
Synthesis of Nano curcu
Stock of curcumin solution (5 mg/ml) was prepared by
dissolving curcumin powder in Dichloromethane (20 ml).
One ml of stock solution was added to boiling water
(50 ml) in drop-wise manner under ultrasonication condi-
tion with an ultrasonic power and frequency of 50 kHz.
The solution was sonicated for about 30 min. After
sonication, the mixture was stirred at 800 rpm for about
20 min till the orange colored precipitate was obtained.
Thereafter, supernatant was discarded and the pellet ob-
tained was used for further study.
Preliminary detection of Nano curcu by UV–visible
spectroscopy
The preliminary detection of synthesized Nano curcu was
carried out by UV–visible spectrophotometer (Shimadzu
UV-1700, Japan), scanning the absorbance spectra in the
range of 200–800 nm wavelength.
Characterization of Nano curcu
Nanoparticle tracking analysis system (NTA)
To determine average size and size distribution of Nano
curcu, NTA analysis was performed by LM 20 (Nanosight
Pvt. Ltd., UK). Liquid sample of Nano curcu was intro-
duced into a scattering cell through which a laser beam
(approx. 40 mW at k = 635 nm) was passed. Particles
present within the path of the laser beam were observed via
a dedicated non-microscope optical instrument LM 20
having CCD camera. The motion of the particles in the
field of view (approx. 100 9 100 lm) was recorded (at 30
fps), and from the subsequent video and images, size of
particles was calculated.
Fourier transform infrared spectroscopy (FTIR)
Nano curcu were characterized by FTIR (Perkin-Elmer
FTIR-1600, USA) mixing dried powder of nanoparticles
with KBr. Spectra were taken in the range of
500–2000 cm-1 at a resolution of 4 cm-1. The data of
FTIR reveal information about functional groups which are
present in the Nano curcu.
Zeta potential measurement
Zeta potential measurements of synthesized nanoparticles
were performed with Zetasizer Nano ZS 90 (Malvern In-
strument ltd, UK) by using zeta dip cells. Zeta potential of
synthesized nanoparticles was analyzed to determine the
charges present on the surface of nanoparticles and its
992 3 Biotech (2015) 5:991–997
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stability at pH 7. The samples for analysis were prepared
by mixing of Nano curcu colloid in dichloromethane in
1:10 proportion. For measuring zeta potential, 1000 ll of
the sample was taken in clear disposable zeta cells.
Transmission electron microscopy
Transmission electron microscopic analysis (TEM) was
useful to determine the size and topology of synthesized
Nano curcu. A drop of solution containing Nano curcu was
placed on the carbon-coated copper grids and kept in in-
frared light until sample gets dried. After drying, powder of
nanoparticles was loaded on specimen holder. TEM mi-
crographs were taken by analyzing the prepared grids on
Philips CM 200 super twin’s TEM operating at 200 kV
(0.23 nm resolution) instrument.
X-ray diffraction method
X-ray diffraction is the method to determine crystalline
structure or phase of crystal. Dried Nano curcu powder was
used for analysis purpose. The diffraction patterns were
recorded by PAN analytical X PRT PRO, D-8, Advanced
Brucker instrument (The Netherlands).
In vitro evaluation of antibacterial activity of Nano
curcu
Test bacteria
Escherichia coli (ATCC 14948) and S. aureus (ATCC
333591) were procured from American Type Culture
Collection Center, USA, and P. aeruginosa (MTCC 4676)
from Microbial Type Culture Collection, Chandigarh. The
antibacterial activity of the Nano curcu and silver
nanoparticles was assessed against test bacteria by using
Kierby–Bauer disc diffusion method (Bauer et al. 1960).
Antibiotics chloramphenicol and gentamycin were used as
standard, while performing antibacterial activity of
nanoparticles. These plates were then incubated at 37 C
for 24 h. Zones of inhibition were measured.
Formulation of antibacterial cream
It was performed in two phases, that is, in water and oil
phase. In water phase, 40 ml of distilled water was taken in
beaker. Then, cetostearyl alcohol (8 g) was added and it
was heated slightly to dissolve completely. It was followed
by addition of methyl paraben (0.3 g) and dissolved by
heating. Then, 30 g of glycerol was added followed by
tween 80 (3.6 g). All the above components were mixed
together (except drug) which results in the formation of
water phase.
For oil phase, liquid paraffin (5 g) was taken in a separate
beaker and it was heated. Then, white paraffin (10 g) was
taken in another beaker and heated later, and liquid paraffin
was mixed with it which results in the formation of oil
phase. After the formation of both the phases, they were
mixed together drop by drop with continuous stirring. After
mixing of both the phases, Nano curcu (5 mg ml-1) were
added to the mixture by continuous stirring on magnetic
stirrer to dissolve the drug properly.
Results
Nano curcu detection was done by UV–visible spec-
troscopy and it was scanned in the range of 200–800 nm.
The absorption spectra of curcumin in dichloromethane
(control) and synthesized Nano curcu showed absorbance
peak at 419 nm which is the characteristic feature of Nano
curcu (Fig. 1). Further characterization of Nano curcu was
performed by nanoparticles tracking and analysis system
(NTA) to determine the average size and particle size
distribution. From the NTA analysis, the mode value was
found to be 92 nm, with the average size of 110 nm
(Fig. 2). FTIR spectrum of curcumin in dichloromethane
(control) and Nano curcu (experimental) was recorded. In
FTIR spectrum of Nano curcu, peaks were observed at
1626, 1454, 1146 and 1037 cm-1 (Fig. 3). The zeta
Fig. 1 UV–vis spectra of synthesized Nano curcu. (Spectra A-cur-
cumin powder in dichloromethane, Spectra B-Nano curcu). Inset fig
comparative solubility of curcumin powder and Nano curcu. a Cur-
cumin in water, b Nano curcu in water
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potential of Nano curcu was found to be -18 mV which
showed moderate stability of Nano curcu (Fig. 4). The
magnitude of the zeta potential gives an indication of the
potential stability of the colloidal system. It is the potential
which is measured, when one measures the velocity of the
particles in a D.C. electric field. TEM analysis was per-
formed to determine the size and shape of nanoparticles. It
was found that Nano curcu showed spherical shape and
polydisperse particles having the size range of 60–80 nm
(Fig. 5). X-ray diffraction analyses are applied to deter-
mine the crystalline nature of Nano curcu. X-ray diffrac-
tograms of synthesized Nano curcu showed characteristic
peaks at diffraction angle of 2h at 23.03, 24.60, and 25.55
(Fig. 6).
The antimicrobial activity of Nano curcu was tested
against E. coli (ATCC 14948), S. aureus (ATCC 333591),
and P. aeruginosa (MTCC 4676) (Fig. 7) by using Kierby–
Bauer disc diffusion method. In the present study, Nano
curcu, silver nanoparticles, combination of silver and Nano
curcu, and antibiotics chloramphenicol and gentamycin
were used to determine antibacterial activity. Nano curcu
were found more effective (12 mm) against P. aeruginosa,
whereas less effective (10 mm) against S. aureus. Silver
nanoparticles were most effective against P. aeruginosa and
less effective against S. aureus. Commercially available
antibiotic chloramphenicol was found to be more effective
against S. aureus (40 mm) and less effective against E. coli
(29 mm). P. aeruginosa was susceptible to antibiotic gen-
tamycin, whereas S. aureus was less susceptible to gen-
tamycin (Fig. 7). Formulated cream (Fig. 8) of Nano curcu
was found to be much more effective against P. aeruginosa
(30 mm) and less effective against S. aureus (20 mm)
(Fig. 9).
Discussion
To confirm the synthesis of Nano curcu, solubility testing
was performed in which Nano curcu were soluble in
water, while curcumin powder was not soluble in water
Fig. 2 Nanoparticles tracking and analysis system (NTA) shows the
size of Nano curcu
Fig. 3 FTIR spectra of Nano curcu. a Experimental-Nano curcu,
b control-curcumin in dichloromethane
Fig. 4 Zeta potential
measurement of Nano curcu
(-18 mV)
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(Fig. 1 inset). It confirms the synthesis of Nano curcu. The
results of UV–visible spectroscopy obtained in our study,
corroborate with the result of Alam et al. (2012) and
Ghosh et al. (2011) which specifies the synthesis of Nano
curcu. The findings of NTA are similar with results ob-
tained by Montes et al. (2010) for determining the size of
polystyrene nanoparticles. In FTIR analysis, peaks cor-
respond to different functional groups. Among these, the
absorption peak at 1626 cm-1 can be assigned for C=C
stretching, 1452 cm-1 corresponds to C=H, and the ab-
sorption at 1146 cm-1 due to C–H stretching. The ab-
sorption peak at 1037 cm-1 might be due to C–N stretch.
The absorption spectra of control might be attributed to
the functional group such as benzene ring, C–O–C bond,
Fig. 5 TEM image showing size and shape of Nano curcu






























Fig. 7 Antibacterial activity of Nano curcu against E.coli, S.aureus,
P.aeruginosa. CUNPs Nano curcu, SNPs silver nanoparticles,
CUNPs?SNPs Nano curcu?silver nanoparticles, Ab (Chl) antibiotic
chloramphenicol, Ab (Gen) antibiotic gentamycin
Fig. 8 Formulated cream containing Nano curcu. a Control cream
(without nanoparticles), b formulated cream (with nanoparticles)
Fig. 9 Antimicrobial activity of cream against pathogenic bacteria.
Control cream without nanoparticles, Cream cream with nanoparti-
cles, CUNPs Nano curcu
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and aromatic C–H stretching. These finding are supported
by many researchers (Yadav et al. 2009; Yen et al. 2010;
Sav et al. 2012). Zeta potential measurement is used to
characterize the surface charge of Nano curcu. The
nanoparticles in colloidal suspension or emulsion carry
electric charge which may be positive or negative. The
synthesized Nano curcu were moderately stable. The
X-Ray diffraction pattern confirms the crystals of Nano
curcu which correspond with the results obtained by Sav
et al. (2012) and Yen et al. (2010). Antibacterial activity
of Nano curcu and silver nanoparticles alone was found to
be more or less similar. But when Nano curcu and silver
nanoparticles both were used in combination, it showed
less zone of inhibition as compared with silver and Nano
curcu when it is tested singly against different bacteria.
Gentamycin showed higher activity against Gram-nega-
tive bacteria, whereas chloramphenicol showed better
action against Gram-positive bacteria. From in vitro an-
tibacterial assay of Nano curcu, it was found that Nano
curcu showed better antimicrobial activity against Gram-
negative bacteria as compared to Gram-positive ones,
whereas bulk curcumin is more effective against Gram-
positive bacteria. The variation in activities among bac-
teria may reflect differences in cell wall structures and
composition between Gram-negative and Gram-positive
bacteria.
Proposed mechanism of antimicrobial activity
of Nano curcu
The phenolic group in Nano curcu interacts with outer
lipopolysaccharide layer present in the Gram-negative
bacteria. Moreover, less peptidoglycan content helps in the
weakening and breakage of bacterial cell wall, resulting in
the death of the bacterial cell. In addition, antibacterial
cream of Nano curcu possesses both the water phase and
oil phase. Both the phases are stabilized by surfactant. The
oil phase of the cream helps in the better interaction of
Nano curcu with the outer lipopolysaccharide layer present
in the Gram-negative bacteria, thereby causing the dis-
ruption of the less rigid cell wall of the Gram-negative
bacteria (Fig. 10).
Conclusions
Nano curcu were fabricated by physico-chemical method.
It is simple, natural, and easy method used for the synthesis
of Nano curcu. Synthesized nanoparticles showed its effi-
cacy against bacteria, viz., E. coli, S. aureus, and P. aer-
uginosa. It can be concluded from the results that Nano
curcu synthesized by sonication method inhibited activity
of bacteria. The formulated cream is new generation of
Fig. 10 Proposed mechanism
for antimicrobial activity of
Nano curcu
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antiseptic cream, which could be used in the treatment of
infection caused by E. coli, S. aureus, and P. aeruginosa.
The Nano curcu could also be used for wound healing.
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